Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
BMC Cancer
; 23(1): 1017, 2023 Oct 23.
Article
en En
| MEDLINE
| ID: mdl-37867191
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
Límite:
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article